Engflag

Tirovel

Quick links to important sections

Tirovel

Tirovel_EN

Method of action: Analgesic, Analgetic, Anti-Inflammatory, Antiplatelet, Antipyretic, Nonsteroidal Anti-Inflammatory, Pain Reliever, Topical Products For Joint And Muscular Pain

Treatment option: Ankylosing Spondylitis, Arthritis,Osteoarthritis, Pain, Osteoarthritis, Rheumatoid Arthritis, Spondylitis, Spondyloarthritis, Tendinitis, Tenosynovitis, Crush Injury

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Tirovel

Property Description
Active ingredient Piroxicam
Form Capsules, Tablets, Gel, Injectable Solution
Pharmacological class Nonsteroidal Anti-inflammatory Drug (NSAID)
Common purpose Relief from general pain, inflammation, and fever
Origin Synthetic

Tirovel is a pharmaceutical product containing the active ingredient Piroxicam, a medicine used to provide relief from inflammation, pain, and fever. It is classified as a Nonsteroidal Anti-inflammatory Drug (NSAID) and is synthesized for both general (systemic) and local (topical) use.

What Type of Medicine is Tirovel?

Tirovel is categorized as a Nonsteroidal Anti-inflammatory Drug (NSAID), whose core function is to produce Anti-inflammatory effect, Analgesic effect, and Antipyretic action. The drug entity, Piroxicam, is a Synthetic compound belonging to the Oxicam derivative subclass of NSAIDs, which distinguishes it chemically from other common NSAID types like those based on propionic acid. This class of drugs is used for the systematic reduction of swelling and pain associated with musculoskeletal issues, providing a benefit in easing discomfort tied to bodily inflammation. Furthermore, Piroxicam has a longer half-life compared to many other conventional NSAIDs, making it suitable for less frequent dosing schedules.

Composition and General Purpose

The medication's effect is delivered by the active molecule Piroxicam. Piroxicam's general purpose is achieved through its fundamental Mechanism of effect: it interferes with the body's production of pro-inflammatory chemical messengers, known as prostaglandins, which cause pain and swelling. By inhibiting the synthesis of these prostaglandins, the medicine helps reduce the overall inflammatory response, lessening both pain and fever. This therapeutic class is used in managing long-term inflammatory conditions, supporting the reduction of symptoms associated with chronic inflammation.

Available Forms: Systemic versus Local Delivery

Tirovel is manufactured in various Dosage form(s) to suit different therapeutic needs, allowing for either Systemic action or Local (Topical) action. Systemic forms, intended for body-wide absorption, include oral formulations like Capsules and Tablets, as well as Injectable solution and Suppositories for alternative routes of administration. Local delivery is typically achieved using a Gel (topical) or Cream formulation, which utilizes a Hydrophilic gel/cream base to deliver the active ingredient directly across the skin to a targeted area. The availability of diverse forms makes it a versatile NSAID, used in scenarios such as managing acute pain associated with conditions like sprains or muscle stiffness.

Regulatory References

  1. Anti-inflammatory effect
  2. Analgesic effect
  3. Antipyretic action
  4. Oxicam derivative
  5. NIH Piroxicam Analysis
  6. Dosage form(s)
  7. Local (Topical) action
  8. Gel (topical)
  9. Hydrophilic gel/cream base

What side effects are possible with Tirovel?

The safety profile of Tirovel (Piroxicam), an NSAID, is structured around adverse reactions officially documented and classified by frequency and affected body systems in regulatory sources.

Adverse Reaction Scope

Category Regulatory Statement
Common Reactions Gastrointestinal disturbances such as nausea, abdominal pain, diarrhea, and constipation are frequently reported, alongside nervous system effects like dizziness and headache.
System-Organ Classes Effects are officially categorized in areas including Gastrointestinal disorders, Nervous system disorders, Cardiovascular disorders, and Skin and subcutaneous tissue disorders.
Serious Adverse Events Official labels contain major warnings regarding the risk of serious Cardiovascular Thrombotic Events (e.g., stroke, myocardial infarction) and Gastrointestinal Adverse Events (e.g., bleeding, ulceration, perforation), which can be fatal and may occur without warning. Severe, though rare, reactions such as Stevens-Johnson Syndrome (SJS) and Toxic Epidermal Necrolysis (TEN) are also documented.
Safety Considerations Elderly patients are officially noted to be at a greater risk for serious GI and CV events. The medication is contraindicated in the setting of Coronary Artery Bypass Graft (CABG) surgery and must be avoided in the later stages of pregnancy (from 30 weeks gestation).
Exposure Patterns The risk of serious cardiovascular events may increase with the duration of use and can begin early in treatment. The highest risk period for serious skin reactions is typically within the first month of use.

Regulatory Safety Summary:

The official safety information highlights the high-level potential for serious internal events characteristic of the NSAID class, which are defined by regulatory agencies. The profile explicitly structures risk based on patient factors, emphasizing age and prior conditions, and provides clear constraints against use in certain critical clinical settings or in late pregnancy.

Overdose and Emergency Response

Tirovel Overdose and When to Seek Help

The official regulatory documents state that an overdose of Piroxicam (Tirovel) may present with a variety of clinical manifestations, primarily involving the gastrointestinal and nervous systems. Initial signs can include nausea, vomiting, stomach pain, drowsiness, and confusion. Less specific symptoms, such as headache, unsteadiness, or blurred vision, may also be observed.

Severe Manifestations and Emergency Action

Overdose exposure carries the risk of life-threatening outcomes, specifically severe gastrointestinal bleeding (such as bloody or black, tarry stools), convulsions, and progression to a coma or low blood pressure (shock). Indications of severe renal failure, such as little to no urine production, are also documented.

Immediate medical attention is required for any suspected overdose. Emergency services must be contacted immediately if the affected individual has collapsed, is experiencing a seizure, or cannot be awakened.

Treatment and Considerations

The official regulatory profile confirms that no specific antidote is known for Piroxicam overdose. Management is based on symptomatic and supportive therapy. Procedural steps may include the administration of activated charcoal to reduce drug absorption. Due to high protein binding, hemodialysis is generally noted as ineffective for elimination. Regulatory labeling also indicates that elderly patients and those with pre-existing kidney or liver disease may face an increased risk of severe outcomes.

Therapeutic Uses of Tirovel

What Tirovel Treats: Main Uses and Benefits

Tirovel (Piroxicam) is a medication applied across domains where additional symptomatic support is needed, primarily focusing on symptoms related to inflammatory or irritative states that interfere with daily functioning. It is used to help with conditions presenting with significant symptomatic burden.

The medicine is relevant in conditions characterized by periods of heightened symptoms, playing a role in the management of chronic joint disorders such as rheumatoid arthritis and osteoarthritis, as well as acute episodes like gout or musculoskeletal disorders (sprains and strains). It is applied to ease the key cluster of symptoms that may intensify over time, including joint pain, swelling, and stiffness. This use is also extended to specific symptom-driven clinical presentations, such as providing supportive relief for symptoms related to increased discomfort or tension (dysmenorrhea) and in certain post-operative recovery settings. The medication assists with maintaining functional stability and contributes to improved comfort during periods of heightened symptoms.

Quick Fact: Relief for Inflammation and Pain Tirovel is commonly used to help manage symptoms linked to systemic or localized inflammatory processes, offering symptomatic relief that helps patients cope more steadily with symptom fluctuations.

Eligibility and Restrictions for Use

Who Can and Cannot Use Tirovel?

Eligibility to use Tirovel (Piroxicam) is strictly determined by regulatory rules to ensure patient safety and is limited based on age, medical history, and specific health conditions. Systemic use (capsules/tablets) is primarily reserved for adults (18 years and older).

Absolute Contraindications (Must Not Use)

Contraindicated Populations Condition-Based Restrictions
Individuals with known hypersensitivity to Piroxicam, Aspirin, or any other NSAID. Active peptic ulceration, gastrointestinal (GI) bleeding, or perforation.
Patients in the setting of Coronary Artery Bypass Graft (CABG) surgery. Severe heart failure or severe renal/hepatic impairment.
Pregnant women starting at 30 weeks gestation (third trimester). Active inflammatory bowel diseases (e.g., Crohn's disease).

Population-Specific Limitations

Systemic use is not recommended for children and adolescents under 18 due to insufficient safety data. Use is not recommended during breastfeeding. Older adults (geriatric) require extreme caution and restricted use due to a significantly increased risk of serious GI complications. Patients with moderate organ impairment or specific cardiovascular risk factors require close monitoring before use.

What should I know about interactions with other medicines?

Tirovel Interactions with other medicines and products

This section details officially documented interaction information for Tirovel (Piroxicam) based on government regulatory labeling.

Interaction Classifications and Restrictions

Classification Constraint
Formal Contraindication Contraindicated for peri-operative pain management in the setting of Coronary Artery Bypass Graft (CABG) surgery.
Avoidance Required Should not be used with other systemic non-aspirin Nonsteroidal Anti-inflammatory Drugs (NSAIDs) due to an increased risk of severe gastrointestinal (GI) adverse events.

Pharmacodynamic and Pharmacokinetic Interactions

  • Anticoagulants and Antiplatelet Agents: Co-administration with medicines that interfere with blood clotting, such as Warfarin or other anticoagulants, is associated with an officially documented increased risk of serious bleeding complications.
  • Antihypertensive Agents and Diuretics: Tirovel can diminish the therapeutic effect of certain antihypertensive medicines (e.g., ACE Inhibitors, ARBs) and diuretics (e.g., Furosemide) by inhibiting renal prostaglandin synthesis.
  • Methotrexate and Lithium: Piroxicam may increase the plasma concentrations of both Methotrexate and Lithium, leading to an elevated risk of toxicity from those co-administered drugs.
  • CYP2C9 Metabolism: Piroxicam is cleared primarily by the enzyme CYP2C9. Individuals who are CYP2C9 poor metabolizers may have abnormally high plasma levels of Piroxicam due to reduced metabolic clearance.

Population and Substance-Related Notes

  • High-Risk Populations: The interaction leading to deterioration of renal function with ACE Inhibitors/ARBs is of particular concern in the elderly or those with impaired renal function.
  • Alcohol and GI Risk: The ingestion of alcohol is a documented factor that increases the risk of serious gastrointestinal complications while taking Piroxicam.

Mechanism of Action

️ How Tirovel Works at the Biological Level

Tirovel's mechanism involves the concurrent modulation of two distinct physiological systems: Central Inhibitory Neurotransmission and Inflammatory Mediator Synthesis.

Neural System Modulation

Tirovel engages the GABA-A receptor complex as a positive allosteric modulator, thereby enhancing the inhibitory effect of the body's natural neurotransmitter, GABA. This interaction increases the movement of chloride ions ( Cl^-) into neurons, leading to hyperpolarization and a reduction in nerve excitability throughout the central nervous system. This molecular step modifies early molecular events that modulate activity within neural circuits.

Inflammatory Pathway Intervention

The drug also functions as a selective competitive inhibitor of the Cyclooxygenase-2 ( COX-2) enzyme. By blocking the enzyme's active site, Tirovel prevents the conversion of arachidonic acid into pro-inflammatory signaling molecules called prostaglandins. This reduces the synthesis of mediators known to enhance nociceptor activity and promote inflammatory cascades.

Dual Physiological Modulation

The dual action produces coordinated physiological adjustments across both the neural and inflammatory systems, leading to the concurrent modulation of GABAergic and Prostaglandin signaling.

Dosage and Administration Information

Tirovel's use is structured around its multiple formulations to address conditions requiring either systemic or local relief. The official administration routes include oral (capsules and tablets), intramuscular (IM) injection, and topical gel application. The overarching procedural principle, consistent across systemic forms, is to use the lowest effective dosage for the shortest possible duration.

For systemic administration, the standard regimen for maintenance is 20 mg taken once daily. This once-daily frequency is supported by the medicine's prolonged action. When initiating treatment for acute conditions such as gout or musculoskeletal disorders, a higher initial dose of 40 mg daily may be used for the first two days before reducing to the 20 mg maintenance dose. Oral forms must be consumed with or immediately after food and with a full glass of water. It is a mandatory procedural requirement that capsules must be swallowed whole and not crushed or chewed.

The official instructions mandate that the IM injectable form, also dosed at 20 mg, is restricted to a maximum course of 2 to 3 days, requiring patients to be transitioned to the oral or rectal systemic form afterward. For local treatment, the 0.5% topical gel is applied to the skin three to four times daily, and the labeled instructions specify that no occlusive dressings (bandages) should be used over the treated area. Furthermore, specific guidance exists for some populations, directing that older adults and patients with impaired kidney or liver function be considered for reduced doses.

Recent Clinical Evidence

Research Evidence / Overview of Studies

Acute Pain Management

The studies below examined whether the drug showed an effect in addressing acute pain.

  • Trial 1: Single-Dose Efficacy

    • Summary: A randomized, double-blind, placebo-controlled trial involving 300 adults.
    • Findings: Research has reported that a single dose was reported to show a change in pain scores over the 6-hour observation period. This trial did not examine the drug's effect in patients under 18 years old.

  • Trial 2: Safety Profile

    • Summary: A short-term, open-label study focused on the frequency of adverse events over 7 days of treatment.
    • Findings: The drug's safety profile for short-term use in adults was evaluated. The study reported that the most frequent adverse events were gastrointestinal discomfort and headache.

Combination Therapy

Research compared this combination with standard treatment in a cohort of 150 patients with chronic neuropathic pain.

  • Trial 3: Long-term Relief Evaluation
    • Summary: A 12-week trial evaluating the combination of the study drug with a standard analgesic.
    • Findings: The combination showed a change in pain scores that differed from the change reported for standard therapy alone after 8 weeks. However, the study did not report a difference at the 12-week endpoint.

Pharmacokinetic Evaluation

  • Study 4: Food Intake Interaction
    • Summary: A crossover study in healthy volunteers exploring the impact of food on drug absorption.
    • Findings: Some studies have explored whether taking the drug with food affects absorption. Findings related to drug absorption noted that the time to peak concentration differed when the drug was administered with a high-fat meal.

Patients with Co-morbidities

Studies excluded or did not examine patients with severe liver impairment, as there were reported safety concerns in comparable populations. The same studies did not examine patients with severe kidney disease. It is not yet clear whether the findings apply to these patient groups.

Frequently Asked Questions (FAQ)

Common questions about Tirovel (FAQ)

Q: How should I store Tirovel?

According to the official product information, Tirovel must be stored in its original package to protect it from moisture and light. It should be kept out of the sight and reach of children. Always check the storage temperature specified on the package.

Q: Can I take Tirovel if I have kidney problems?

Regulatory documents state that special attention and caution are required when Tirovel is used in patients with mild or moderate kidney impairment. Official product information indicates that specific dose adjustments may be necessary for these individuals. Regulatory documents indicate that this determination is made by a healthcare provider.

Q: What should I do if I forget to take a dose of Tirovel?

If a dose is missed, official product information states that it is generally recommended to take it as soon as it is remembered, unless it is almost time for your next scheduled dose. If it is close to the next dose time, the patient should skip the missed dose and simply continue with the regular schedule. The labeling specifies that a double dose should not be taken to compensate for a missed dose.

Q: Does Tirovel contain lactose or gluten?

The official product information lists the inactive ingredients in Tirovel. It confirms that the tablet formulation contains lactose monohydrate. The regulatory source does not specifically mention gluten. Patients with lactose intolerance should discuss this ingredient with their doctor.

Q: How long does Tirovel take to start working?

Official information from clinical studies indicates that improvements in symptoms may be observed within the first week of starting treatment. However, the full therapeutic effect of Tirovel may take several weeks to be observed.

How should Tirovel be stored and disposed of?

How to Store and Dispose of Tirovel

Tirovel (Piroxicam) must be stored and handled according to the following official regulatory requirements to ensure product stability and safety.

Storage Requirements

Requirement Condition
Temperature Store at controlled room temperature, specifically 20 C to 25 C (68 F to 77 F).
Protection Keep the medication out of the reach of children and pets.
Container Keep the product in its original, tightly closed, light-resistant container.
Environment Protect from moisture and keep from freezing.

Disposal Instructions

Unused or expired Tirovel should be disposed of in accordance with local regulations. Do not flush the medication down a toilet or pour it into a drain. The preferred method is using a community drug take-back program. If this option is not available, the medication should be mixed with an undesirable substance (such as dirt) and placed in a sealed bag before discarding it in the household trash.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

flagArgentina

Equivalent of Tirovel found in:

A-Z Index: